The E2F pathway is activated in 5FU-treated Δ40p53:WTp53 cells. by Cecilia B. Levandowski (11238230)

“…WTp53 cells. <b>(C)</b> The general upstream regulators (IPA) controlling the cellular response to 5FU are similar (shared inside oval) between Δ40p53:WTp53 and WTp53 cells, with a few exceptions (<i>p</i> < 0.01). …”

Image_5_Pex14p Phosphorylation Modulates Import of Citrate Synthase 2 Into Peroxisomes in Saccharomyces cerevisiae.pdf by Andreas Schummer (9378137)

Relationship of clinical measures to gross thalamic volume in CD patients. by Jeff L. Waugh (3170892)

<i>Adgrg6</i> regulates gene expression profiles and STAT3 signaling in ATDC5 cell culture. by Zhaoyang Liu (1493710)

“…<p>(A) Schematic of a 17-bp deletion of <i>Adgrg6</i> from a stable single cell clone of ATDC5 cell line (<i>Adgrg6</i> KO). (B) qPCR analyses of gene expression in ATDC5 cells at 5 and 15 days of maturation demonstrates decreased expression of markers of healthy disc, <i>Col2a1</i>and <i>Sox9</i>, and increased expression of the hypertrophic marker, <i>Col10a1</i> and the extracellular matrix modifying enzyme, <i>Mmp13</i> in <i>Adgrg6</i> KO cells. …”

Image_5_Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.tif by Mario Pérez-Diego (14799367)

Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”